Nomura

A supranational dollar deal ran away with April’s top spot in BondMarker, outstripping the rest of the table by a good margin and clocking in as the third most highly rated deal of the year.

Goldman Sachs-backed ReNew Power is seeking the greenlight for its IPO, having filed a draft red herring prospectus with the Securities and Exchange Board of India on Tuesday.

IndInfravit Trust lifted the gloom in India’s infrastructure investment trust market this week after its Rp32.3bn ($484m) private placement, a first for the asset class, drew in Allianz Capital Partners and Canada Pension Plan Investment Board.

Nomura appointed Ting Lu, a former research head at Huatai Securities, as its chief China economist on Tuesday.

India's IndoStar Capital Finance has announced an indicative price range for its potential Rp18.4bn ($276m) IPO, according to a banker on the deal.

Dan Cohen has left his job as head of high yield trading at HSBC to work for Nomura in the same position.

Japanese pharmaceutical company Takeda has bumped up its debt and equity offer for Shire to £46bn, leading to potentially the largest sterling M&A financing of the year.

Yuexiu Real Estate Investment Trust, the only Chinese Reit to have issued bonds offshore, returned last Friday for a $400m three year deal, pricing it slightly inside its parent company’s curve.

Rating: Aaa/AAA

KommuneKredit took a novel approach to its sterling issuance on Tuesday, adding a switch operation to print its largest ever new issue in the currency. Bankers believe other issuers may use the tactic. Meanwhile, Bank Nederlandse Gemeenten (BNG) received less interest in a sterling trade of its own.

Public sector bankers lined up to laud a new SSA borrower this week, as the International Development Association (IDA) surpassed expectations on its bond debut. Now, many are eager to see the its next move, with many anticipating a Washington supranational with greater currency flexibility, writes Craig McGlashan.

Irish pharmaceutical company Shire has turned down a £42.4bn takeover offer from Takeda, putting pressure on the Japanese company’s ambitions for global expansion as it strives to maintain its dividend and investment grade rating.